Boston Scientific Corporation Website

Boston Scientific Corporation

NYSE-BSX

Income Statement
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Total Revenues

10,735

9,913

11,888

12,682

14,240

15,229

Total Revenues % Chg.

9.3%

-7.7%

19.9%

6.7%

12.3%

13.6%

Cost of Goods Sold, Total

3,103

3,242

3,760

4,003

4,391

4,768

Gross Profit

7,632

6,671

8,128

8,679

9,849

10,461

Selling General & Admin Expenses, Total

3,928

3,787

4,359

4,520

5,190

5,430

R&D Expenses

1,174

1,143

1,204

1,323

1,414

1,468

Amortization of Goodwill and Intangible Assets

699

789

741

803

828

843

Other Operating Expenses, Total

5,801

5,719

6,304

6,646

7,432

7,741

Operating Income

1,831

952

1,824

2,033

2,417

2,720

Interest Expense, Total

-473

-361

-341

-470

-265

-276

Interest And Investment Income

30

3

4

10

22

22

Net Interest Expenses

-443

-358

-337

-460

-243

-254

Currency Exchange Gains (Loss)

-35

-32

-27

-31

-41

-23

Other Non Operating Income (Expenses)

1

6

-7

-14

-16

5

EBT, Excl. Unusual Items

1,354

568

1,453

1,528

2,117

2,448

Restructuring Charges

-83

-179

-40

-24

-69

-38

Merger & Related Restructuring Charges

-369

—

—

—

—

—

Impairment of Goodwill

—

—

—

—

—

—

-73

—

—

—

—

Gain (Loss) On Sale Of Investments

-30

383

250

-1

-59

-58

Gain (Loss) On Sale Of Assets

—

—

—

—

—

—

78

-22

—

—

Asset Writedown

-105

-452

-370

-132

-58

-277

Legal Settlements

-115

-278

-430

-173

111

111

Other Unusual Items

35

-49

136

-35

-58

-45

EBT, Incl. Unusual Items

687

-80

1,077

1,141

1,984

2,141

Income Tax Expense

-4,013

2

36

443

393

319

Earnings From Continuing Operations

4,700

-82

1,041

698

1,591

1,822

Minority Interest

—

—

—

—

—

—

—

—

—

1

5

Net Income

4,700

-82

1,041

698

1,592

1,827

Preferred Dividend and Other Adjustments

—

—

—

—

—

—

33

56

56

22

-1

Net Income to Common Incl Extra Items

4,700

-115

985

642

1,570

1,828

Net Income to Common Excl. Extra Items

4,700

-115

985

642

1,570

1,828

Total Shares Outstanding

1,394.9

1,416.6

1,425.5

1,433.3

1,465.7

1,471

Weighted Avg. Shares Outstanding

1,391.5

1,416.7

1,422.3

1,430.5

1,453

1,467.3

Weighted Avg. Shares Outstanding Dil

1,410.6

1,416.7

1,433.8

1,439.7

1,463.5

1,479.5

EPS

3.4

-0.1

0.7

0.4

1.1

1.2

EPS Diluted

3.3

-0.1

0.7

0.4

1.1

1.2

EBITDA

2,842

2,075

2,917

3,169

3,613

3,948

Effective Tax Rate

-584.1%

-2.5%

3.3%

38.8%

19.8%

14.9%